ARCHIVES

Adverse Events Of Chemo More Common Than Expected

This article is from The Cancer Letter archive.

Vol. 29 No. 8 | August 25, 2006

Download PDF Visit The Full Archive

Related Articles

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

In Brief: Morton Leaves UCLA Surgical Oncology; Rall Resigns As NIH Deputy for Intramural Research

May 17, 1991

NCI Cooperative Group Clinical Trials Listed

April 24, 2009

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

FDA Approves Genetic Test For Breast Cancer Patients

January 25, 2008

High-Priority Radiation Therapy Research Projects Approved By DCT Board of Counselors

March 26, 1976